HALISTER: Alexion CEO Says FDA’s Strensiq Decision Due in Matter of Weeks

Alexion CEO Says FDA’s Strensiq Decision Due in Matter of Weeks

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
ALXN US (Alexion Pharmaceuticals Inc)
3400398Z US (HHS Food & Drug Administration)

People
David Hallal (Alexion Pharmaceuticals Inc)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283